Human GFAP ELISA KIT
Catalog EF000292
Packing 48T/96T
Reactivity Human
Detect Range 0.313-20ng/ml
GFAP ELISA KIT Sensitivity< 0.1ng/ml
Application Human GFAP ELISA KIT is for detecting the concentration of Human GFAP in serum, plasma, tissue homogenates and other biological fluids.
Storage condition 6 month at 4 Centigrade
Alternative name: wu:fb34h11; ALXDRD; cb345; etID36982.3; FLJ42474; FLJ45472; GFAP; GFAP_HUMAN; gfapl; Glial fibrillary acidic protein; Intermediate filament protein; wu:fk42c12; xx:af506734; zgc:110485;
GFAP (Glial fibrillary acidic protein) Description:
GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.The cytoskeleton consists of three types of cytosolic fibers: microfilaments (actin filaments), intermediate filaments, and microtubules. Major types of intermediate filaments are specifically expressed in particular cell types: cytokeratins in epithelial cells, glial fibrillary acidic protein (GFAP) in glial cells, desmin in skeletal, visceral, and certain vascular smooth muscle cells, vimentin in cells of mesenchymal origin, and neurofilaments in neurons. GFAP and vimentin form intermediate filaments in astroglial cells and modulate their motility and shape (1). In particular, vimentin filaments are present at early developmental stages, while GFAP filaments are characteristic of differentiated and mature brain astrocytes. Thus, GFAP is commonly used as a marker for intracranial and intraspinal tumors arising from astrocytes (2). In addition, GFAP intermediate filaments are also present in non-myelin-forming Schwann cells in the peripheral nervous system (3).
Principle of Human GFAP ELISA KIT
The microtiter plate provided in Human GFAP ELISA KIT has been pre-coated with an Human GFAP antibody specific to Human GFAP. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated Human GFAPantibody preparation specific for Human GFAP then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Human GFAP, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm . The concentration of Human GFAPin the samples is then determined by comparing the O.D. of the samples to the standard curve.
*Please noted that Human GFAP ELISA KIT is only for RUO (Research Use Only), Not for the diagnostic Purpose!
Technical Principle & Methodology
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway:
Double Antibody Sandwich Method
(双抗体夹心法). This ensures maximum reproducibility across clinical research and scientific workflows.